(Q58619928)

English

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Willem J Lesterhuis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gerty Schreibelt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jolanda de Vries

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Sandra Croockewit

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Nicole M Scharenborg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

H Mary-lène H Brouwer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marie-Jeanne P Gerritsen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Pierre G Coulie

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gosse J Adema

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Cornelis J A Punt

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

11 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

249-260

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

https://scigraph.springernature.com/pub.10.1007/s00262-010-0942-x

0 references

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Dendritic cell vaccines in melanoma: from promise to proof?

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Phenotypical and functional characterization of clinical grade dendritic cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Diversity and recognition efficiency of T cell responses to cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0942-X

21 January 2018

Identifiers

10.1007/S00262-010-0942-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069321%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58619928&oldid=2120011036"